http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
어린이 김치 표준화에 대한 연구(1) : 어린이 김치의 담금법 개발 Development of the Preparation of Kimchi for the Children
송영옥,전영수,권명자,빈성미,김은희,문정원,김명 부산대학교 가정대학 1995 家政大學硏究報告 Vol.21 No.-
The purpose of this study is reporting the results of first trial for the standardization of children's kimchi in terms of brining standardization, development for the recipe ad pannel test for the children's kimchi. In order to develop the standard recipe for children's kimchi, our research team have visited kimchi factories, temples and houses located in Pusan and Kyung-Sang Nam Do province. Three kinds of chinese cabbage kimchi (hamyang, haeundae, and jinrae kimchi named by region where we collected) which got the top three highest score in panel testing was selected. The original recipes of these kimchi were sightly modified to prepared the kimchi at laboratory. Among three of them, hamyang kimchi which contained dried anchovy power was selected as a model kimchi for development of the children's kimchi recipe. We find out that the optimal salt concentration of brined cabbage and kimchi for the children's kimchi (sliced style kimchi, approximately 2.5X3cm a piece) that showed the hightest pennel score were approximately 1.5% and 2.0%, respectively. The salt concentration of brined cabbage became 1.5, 1.43, and 1.60% after 60 min at 10% brining solution, 45 min at 12% and 30 min at 15%, respectively. The developed recipe used for the children's kimchi at our team is as follows. The major ingredients used for the preparation of kimchi is brined sliced chinese cabbage (salt concentration is 1.5%) 1kg galic 11g, ginger 5.0g, red pepper powder 20.0g, fermented anchovy juice 25.0g, fermented shrimp juice 5.0g dried anchovy and sea weed extracts 30.0g, anchovy power 2.4g glutinious rice gel 40.0g, starch syrup, 10.0g, and apple juice 22.5g. The total acceptability test of developed children's kimchi (test kimchi) was carried out with 84 of 6th grade student during lunch time at elementary school in Pusan where has a school lunch program. Sixty nine percent of student answered test kimchi is very good, 25% of them said it is fair, and only 6% of students answered they didn't like test kimchil. However, for the kimchi supplied from school at lunch, 52% students answered the kimchi is good, 26% of them said it is fair, and 22% of them said they don't like school supplied kimchi. This result tells us that the test kimchi is better than school supplied kimchi and the test kimchi can be developed further as a children's kimchi.
張明洙,宋浚泰 全北大學校 附設 都市및環境硏究所 1990 都市 및 環境硏究 Vol.5 No.-
The purpose of this study is to, through the research of the history of Chonju, find out the object of restoration among historic remains damaged artificially, preserve the characteristics of the areas in which historic remains existing right now are cellectively distributed and to re-organize their historic environment coupled with cultural individuality and peculiarity. The results of the study are summarized as follows; First, the East gate, the West gate, and the North gate except for the presently existing the South gate should be restored, and Sun Hwa Dang which was the center of Kwan-A in the old castle (old Chonju city) and other accessory buildings restored. Second, in order to solve these problems mentioned above, I propose that area of human activity, one of the elements for urban landscape, be organized.
( Myeong Jun Song ),( Si Hyun Bae ),( Sung Won Lee ),( Do Seon Song ),( Young June Lee ),( Ho Jong Chun ),( Jong Young Choi ),( Seung Kew Yoon ),( Nam Ik Han ),( Sang Wook Choi ),( Young Sok Lee ),( C 대한간학회 2013 춘·추계 학술대회 (KASL) Vol.2013 No.1
Background: The purpose of this study was to evaluate the recurrence of hepatocellular carcinoma and the survival rate of patients who received radiofrequency ablation (RFA) after transarterial chemoembolization (TACE) with that of patients treated with TACE or RFA alone. Methods: Two-hundred and one patients with HCC were consecutively enrolled at Seoul St. Mary`s hospital between Dec, 2004 and Feb, 2010. Inclusion criteria were a single HCC≤5.0 cm or up to three HCCs≤3.0 cm, with no vascular invasion or extrahepatic metastasis. In all, HCC patients (n=87) who had undergone RFA after TACE and those who received TACE (n=71) or RFA only (n=43) were analyzed. Propensity scores were generated to select from each arm of the study. Results: Median follow-up periods were 33.3 months (6.8-80.9 months). The recurrence rates at 1, 3, and 5 years in the TACE+RFA and RFA groups were similar (6, 33, and 54%; and 10, 31, and 48% respectively); however, those in the TACE group were higher (17, 58, and 78%, respectively). In the TACE+RFA group, the local recurrence rates were significantly lower compared with the RFA group (P=0.034). The overall survival rates at 1, 3, and 5 years in the TACE+RFA group (98, 95, and 90%, respectively) were superior to those in the TACE or RFA groups (98, 90, and 83%; 94, 84, and 71%; P=0.064, 0.011, respectively). In a multivariate analysis of overall survival using a Cox regression model, combination treatment was a significant independent factor for survival compared to RFA and TACE monotherapy (HR, 0.371; 95% CI, 0.141-0.973; P=0.0371, HR, 0.476; 95% CI, 0.230-0.986; P=0.046, respectively) Conclusion: The combination of TACE and RFA is an effective treatment for early-stage HCC and results in lower local recurrence and better overall survival rates than those achieved by RFA or TACE alone.
( Myeong Jun Song ),( Jeong Won Jang ),( Si Hyun Bae ),( Jong Young Choi ),( Seung Kew Yoon ),( Hee Yeon Kim ),( Chang Wook Kim ),( Do Seon Song ),( U Im Chang ),( Jin Mo Yang ),( Chan Ran You ),( San 대한간학회 2017 춘·추계 학술대회 (KASL) Vol.2017 No.1
Aims: We aimed to evaluate the efficacy and safety of tenofovir disoproxil fumarate (TDF) therapy in naïve chronic hepatitis B (CHB) patients for 144 weeks in Korean real life practice. Methods: 579 naïve CHB patients at 12 medical centers were enrolled from Sep, 2015 to Jan, 2016 by retrospective and prospective design (NCT02533544). We compared the virological responses (HBV DNA< 116 copies) and renal safety of treatment naive patients. Results: In this cohort, 465 (80.3%), 298 (51.4%) and 157 (27.1%) CHB patients completed 48, 96, and 144 weeks, respectively. Overall complete virological response (CVR) showed 59.5%, 78.1%, and 79.6% of patients at week 48, 96, and 144 respectively. In HBeAg positive CHB, CVR at week 48, 96 and 144 showed 49.0%, 71.7% and 78.4%, respectively. HBeAg loss and seroconversion rate at week 46, 96, and 144 showed 17.8%, 22.7%, 36.3%, and 7.8%, 9.2%, 14.7%, respectively. In HBeAg negative CHB, CVR at week 48, 96 and 144 showed 75.0%, 87.5% and 81.3%, respectively. Overall ALT normalization showed 76.2%, 81.1%, and 84.11% of patients at week 48, 96, and 144 respectively. In multivariate analysis, HBeAg positive showed independent factors of CVR at week 46 and 96, although baseline HBV DNA was independent factor of CVR at week 48. However, at week 144, there was no significant factor of CVR including viral factors, BMI, and comorbidities. In renal safety, 2(0.9%) CHB patients showed elevated creatinine ( >0.5mg/dL). In analysis for change of eGFR, older age (≥65) showed significant reduction at week 48 and 96 (P=0.00415 and 0.0412, respectively). Comorbidities (diabetes or hypertension) also significantly showed reduction at week 48 (P=0.0098). Conclusions: TDF therapy demonstrated sustained viral suppression and a favorable safety throughout 3 years. However, close monitoring of eGFR should be mandatory when treating CHB patients receiving TDF, particularly those with older age or comorbidities.
( Myeong Jun Song ),( Do Seon Song ),( Hee Yeon Kim ),( Sun Hong Yoo ),( Chung Hwa Park ),( Si Hyun Bae ),( Jong Young Choi ),( U Im Chang ),( Jin Mo Yang ),( Seung Kew Yoon ) 대한간학회 2012 춘·추계 학술대회 (KASL) Vol.2012 No.1
Background: Transarterial chemoembolization (TACE) has been widely used as treatment in hepatocellular carcinoma. In order to maximize the therapeutic efficacy, Doxorubicin loaded drug eluting bead has been developed to deliver higher doses of chemotherapeutic agent and to prolong contact time with tumor. The purpose of this study was to evaluate the efficacy and safety of DC bead® TACE in comparison with conventional TACE. Methods: One hundred twenty nine patients who underwent TACE between Aug. 2008 and Feb. 2011 were retrospectively enrolled. We compared HCC patients (n=60) who had underwent TACE with DC bead® to controls (n=69) who had received conventional TACE. The primary endpoint was treatment response according to modified RECIST criteria, time to recurrence and overall survival. The primary safety endpoint was treatment-related liver toxicity. Results: The objective response rates of the DC bead® group were significantly better than that of conventional TACE group (81.6 vs 49.2 %, p <0.001). Subgroup analysis conducted in patient with intermediate stage confirmed significantly higher objective response and longer time to progression rates in patients receiving DC bead® than those treated with conventional TACE (p<0.001, p=0.038, respectively). DC bead group showed significant overall survival benefit (p=0.005). There was no statistically significant difference in liver toxicity between the DC bead® and conventional TACE group (p >0.05). Conclusions: Transarterial chemoembolization with DC bead® showed better treatment response and time to progression rates compared with conventional TACE. DC bead® TACE may appear to be a feasible and promising approach in the treatment of HCC.
Song, Myeong Jun,Kim, Il To,Kim, Young Bok,Kim, Jiwon,Shin, Moo Whan Elsevier 2017 ELECTROCHIMICA ACTA Vol.230 No.-
<P><B>Abstract</B></P> <P>Lithium–oxygen (Li–O<SUB>2</SUB>) batteries are promising candidates for high<B>-</B>performance energy storage systems because of their tremendous energy density, which significantly exceeds that of conventional Li–ion batteries. Cobalt oxide (Co<SUB>3</SUB>O<SUB>4</SUB>) is considered an effective catalyst for non<B>-</B>aqueous Li-O<SUB>2</SUB> batteries owing to its excellent oxygen reduction and oxygen evolution reaction activity. However, low electrical conductivity and agglomeration of Co<SUB>3</SUB>O<SUB>4</SUB> can degrade the electrochemical performance properties. We present a facile method of synthesizing porous carbon/Co<SUB>3</SUB>O<SUB>4</SUB> composites derived from metal–organic frameworks (MOFs) via post-thermal treatment for use as the cathode in rechargeable Li–O<SUB>2</SUB> batteries. Use of cobalt-containing MOFs as a sacrificial template produces uniformly distributed Co<SUB>3</SUB>O<SUB>4</SUB> nanoparticles in the carbonaceous matrix, alleviating the problems of using only Co<SUB>3</SUB>O<SUB>4</SUB> as the cathode material. As-synthesized porous carbon/Co<SUB>3</SUB>O<SUB>4</SUB> composites show superior electrochemical performance, for example, a low overpotential and high reversible capacity of about 9850mAhg<SUP>−1</SUP> at a current density of 100mAg<SUP>−1</SUP>. They also exhibit excellent cyclability up to the 320th cycle, with a limited capacity of 500mAhg<SUP>−1</SUP> at a current density of 200mAg<SUP>−1</SUP>. The improvement is attributed to the catalytic activity and mesoporous structure of uniformly distributed Co<SUB>3</SUB>O<SUB>4</SUB> nanoparticles in the carbonaceous matrix.</P> <P><B>Highlights</B></P> <P> <UL> <LI> We develop porous carbon/Co<SUB>3</SUB>O<SUB>4</SUB> composites for Li–O<SUB>2</SUB> batteries. </LI> <LI> Porous carbon/Co<SUB>3</SUB>O<SUB>4</SUB> composites are derived from cobalt-containing MOFs. </LI> <LI> Co<SUB>3</SUB>O<SUB>4</SUB> nanoparticles catalyze both ORR and OER in a rechargeable Li–O<SUB>2</SUB> system. </LI> <LI> The porous structure of the composites realizes a high discharge capacity. </LI> <LI> The uniform distribution of Co<SUB>3</SUB>O<SUB>4</SUB> realizes effective catalytic effects. </LI> </UL> </P>